Sentences with phrase «with schizophrenia patients»

Studies with schizophrenia patients and healthy controls (HC) indicate that the

Not exact matches

A «brain training» iPad game developed in Britain may improve the memory of patients with schizophrenia, helping them in their daily lives at home and at work, researchers said on Monday.

ALKS 3831: Enrollment completed for ENLIGHTEN - 2, a six - month weight study compared to olanzapine in patients with stable schizophrenia.

I discovered that mental health practitioners do wonder why religious delusions / hallucinations are so prominent in patients with serious mental health diagnoses, especially schizophrenia — why do the delusions / hallucinations experienced by these persons have a religious theme?

The Muotri lab uses induced pluripotent stem cells from patients with autism and schizophrenia to look for biomarkers of these conditions.

«The interaction between the two types of neurons could also help explain the presence of seizures in patients with schizophrenia, dementia and some forms of autism.»

Using a new kind of MRI measurement, neuroscientists reported higher levels of oxidative stress in patients with schizophrenia, when compared both to healthy individuals and those with bipolar disorder.

Among 21 patients with chronic schizophrenia, Du observed a 53 % elevation in NADH compared to healthy individuals of similar age.

The UI study, which was published March 28 online in the journal Molecular Psychiatry, adds to the accumulating evidence, including recent human studies from Harvard University, that suggests cerebellar stimulation might help improve cognitive problems in patients with schizophrenia.

Altered patterns of variability were observed in the brain's default network with schizophrenia, autism and Attention Deficit Hyperactivity Disorder (ADHD) patients.

Early experimental studies from Harvard in patients with schizophrenia suggest that cerebellar stimulation is safe and appears to improve some of the patients» cognitive abnormalities.

Compared to healthy individuals, patients with schizophrenia performed poorly on the timing task.

Scientists have theorized that this reduction in glutamate activity, and therefore the higher KYNA levels seen in patients, might be connected with a range of symptoms seen in schizophrenia, especially cognitive problems.

Working with this hypothesis, the researchers conducted a statistical analysis of the CX3CR1 gene in over 7000 schizophrenia and autism patients and healthy subjects, finding one mutant candidate, a single amino acid switch from alanine to threonine, as a candidate marker for prediction.

They found that schizophrenia patients, especially those with prominent negative symptoms, were more likely to choose the less demanding tasks that provided smaller rewards and were less likely than healthy subjects to choose more demanding tasks that offered greater rewards.

In the current study, researchers analyzed 48 ethnically diverse patients diagnosed with schizophrenia, looking at symptom sets in patients found to have rare or previously unknown changes in the DNA code of the four genes that disrupted brain function.

Patients with schizophrenia struggle to interpret reality, typically suffering from hallucinations, learning disabilities, emotional withdrawal and lack of motivation.

Now a large survey using data from all patients hospitalized in psychiatric wards in Israel, and their siblings, has given some answers: having a sibling with schizophrenia increases your risk of developing the condition by a factor of x10, with increased risks of developing bipolar disorder and other mental disorders.

It was intended to keep patients safely asleep during surgeries, but many woke up with symptoms similar to those experienced by people with schizophrenia, including hallucinations and the disorientation of feeling «dissociated» from their limbs, resulting in PCP being abandoned for clinical purposes.

The study didn't include people with a psychotic disorder, but the findings line up with brain alterations found in patients with schizophrenia.

This study examined the genetic code of affected patients with schizophrenia and their healthy parents to identify newly occurring (sporadic) mutations that disrupted the four influential signaling genes in 31 percent of these patients.

Now an international team has examined the rates of mental disorders in the families of 6111 Israeli patients who had been hospitalised with schizophrenia, bipolar disorder, or depression.

When, for example, subjects were asked 20 times in succession to estimate the duration for which a square — displayed for exactly one second in each case — appeared on the screen, the estimates given by patients with schizophrenia exhibited a much higher level of variability than those of the control group.

Patients with schizophrenia are also less precise when it comes to judging the temporal order of events.

Concerning the problems when it comes to perceiving chronological sequences, these could also be caused by fundamental cognitive deficits in patients with schizophrenia and may not be related to the general way they perceive time.

In a previous study, the researchers showed that a group of self - described voice - hearing psychics had similar voice - hearing experiences as patients with schizophrenia.

«Not so much for patients with schizophrenia, post-traumatic stress disorder or depression.»

For example, by taking neural stem cells from a patient with schizophrenia, researchers might turn back the clock and track the onset of the condition in an organoid.

«We think, in the near future, it will be possible to treat schizophrenia with four injections per year instead of [patients] having to take pills three times a day,» says Husseini Manji, global head of neuroscience R&D at Janssen.

There he came to find that multifamily therapy in schizophrenia worked best when combined with support from social workers, nurses, and psychiatrists to help patients find employment and housing so they could live independently.

Already this has shown that schizophrenia patients have particular problems noticing what has changed in a previously learned scene in which an object has been moved, but do better at recognising when the object has been replaced with something else.

Led by Brenda Penninx, PhD, of the VU University Medical Center in Amsterdam, the Netherlands, the study found that patients with an early age at onset and higher symptom severity have an increased genetic risk for MDD, bipolar disorder and schizophrenia.

They also discovered that compared with healthy controls, patients with first episode schizophrenia had higher levels of insulin and increased levels of insulin resistance, again supporting the notion that this group are at higher risk of developing diabetes.

Using an independent group of 1602 MDD patients and 1390 control participants from the RADIANT - UK study, the researchers also replicated their finding that patients with a high number of DSM symptoms have increased genetic risk for schizophrenia.

Subjects included 119 healthy volunteers and 26,683 patients with a variety of psychiatric conditions such as brain trauma, bipolar disorders, mood disorders, schizophrenia / psychotic disorders, and attention deficit hyperactivity disorder (ADHD).

Researchers might generate personalized brain organoids from the reprogrammed skin cells of individuals with, say, schizophrenia and test which medications work best for patients with particular genetic profiles of the illness.

Of individuals with recent - onset schizophrenia, 29 % exhibited signs of a particular family of retroviruses known as Human Endogenous Retrovirus W (HERV - W), compared with none of the control patients.

They sampled fluid from 20 patients with a long history of schizophrenia, 35 individuals that had recently developed the disorder, and a number of different control groups.

In clinical practice, however, the description of schizophrenia is so broad that there is a risk that numerous patients are wrongly being diagnosed with schizophrenia.

Yet experts have lately come to understand that the prognosis for patients with schizophrenia is not uniformly dire.

I already know, for instance, that patients with schizophrenia have distinctive aberrations in the right superior temporal gyrus and that those with attention - deficit / hyperactivity disorder have smaller brain volumes in all regions.

The same change is seen in patients with neuropsychiatric conditions such as schizophrenia, Down's syndrome, and autism, and in people with poor impulse control.

First, an analysis of genomic data from 6,000 patients with autism spectrum disorders, 1,000 patients with bipolar disorder, and 2,500 patients with schizophrenia by co-first author Pierre - Marie Martin, PhD, a postdoctoral researcher in Cheyette's lab, revealed that disruptive mutations in the main neuronal form of DIXDC1 were present about 80 percent more often in psychiatric patients (0.9 percent had mutations) compared to healthy controls (0.5 percent had mutations).

A DECADE AGO psychologist Ronald Levant, then at Nova Southeastern University, was telling some of his colleagues at a conference about patients with schizophrenia whom he had seen recover.

But a study published in Science [subscription required] in April pointed to one new factor: Patients with schizophrenia frequently have large chunks of DNA added to or missing from their genomes.

Researchers checked the genomes of 150 patients with schizophrenia and those of 268 healthy people, looking for large duplications and deletions of genetic material that disrupted the function of a gene.

«Our results suggest that there are substantial differences between specific antipsychotic agents and between routes of administration concerning the risk of rehospitalization and treatment failure among patients with schizophrenia,» the article concludes.

In this study, the researchers compared the severity of negative symptoms and proline levels in 95 hospitalized schizophrenia patients with variants of the COMT gene.

Antipsychotics were originally developed for use in patients with schizophrenia or psychosis, but the study shows that «off - label» prescribing of these drugs to treat the behavioural and psychological symptoms of dementia is a common practice in care homes.

Among those patients who were being treated with valproate (approximately one - third of the schizophrenia patients), negative symptoms were more severe in those with the Met / Met gene than in those with the Val / Val gene.